Automated scoring of tumor-infiltrating lymphocytes informs risk of death from thin melanoma: A nested case-case study

Affiliations

• ¹ Frazer Institute, University of Queensland, Brisbane, Australia.
• ² Department of Pathology, Yale University School of Medicine, New Haven, Connecticut.
• ³ Frazer Institute, University of Queensland, Brisbane, Australia; Department of Dermatology and Venereology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden; Department of Population Health, QIMR Berghofer Medical Research Institute, Brisbane, Australia.
• ⁴ Department of Pathology, Yale University School of Medicine, New Haven, Connecticut; Department of Oncology and Pathology, Karolinska Institute, Stockholm, Sweden; Department of Clinical Pathology and Cancer Diagnostics, Karolinska University Hospital, Stockholm, Sweden.
• ⁵ Pathology Queensland, Princess Alexandra Hospital, Brisbane, Australia.
• ⁶ Cancer Council Queensland, Brisbane, Australia.
• ⁷ Department of Population Health, QIMR Berghofer Medical Research Institute, Brisbane, Australia; School of Public Health, Faculty of Medicine, University of Queensland.
• ⁸ Frazer Institute, The University of Queensland, Dermatology Research Centre, Brisbane, Australia; Department of Dermatology, Princess Alexandra Hospital, Brisbane, Australia.
• ⁹ Queensland Melanoma Project, University of Queensland, Princess Alexandra Hospital, Brisbane, Australia.
• ¹⁰ Department of Population Health, QIMR Berghofer Medical Research Institute, Brisbane, Australia.
• ¹¹ Frazer Institute, University of Queensland, Brisbane, Australia; Department of Dermatology, Princess Alexandra Hospital, Brisbane, Australia. Electronic address: [email protected].